Alzheimer’s Disease Group 廖元祺 楊熙恆

Slides:



Advertisements
Similar presentations
APOE Genotype Effects on Alzheimer’s Disease Clinical Onset, Epidemiology, and Gompertzian Aging Functions J.Wesson Ashford, M.D., Ph.D. Stanford / VA.
Advertisements

How Biological Factors May Affect Memory
DEMENTIA Presented By Andrea Rose Cadiz Health and Nutrition.
Aging, Memory and Alzheimer’s Disease Kinga Szigeti, MD, PhD.
ADRC Training1 Meeting the Needs of Aging Persons with Developmental Disabilities Cross Network Collaboration for Florida Bridging the Networks - Needs.
Decision presented by the committee board members: Nicholas Mann & Katelyn Strasser FUTURE FUNDING FOR ALZHEIMER’S DISEASE October 14, 2014 MPH 543 Leadership.
ALZHEIMER’S DISEASE BY OLUFOLAKUNMI KEHINDE PRE-MD 1.
Caring for People with Dementia in Primary Care: Diagnosis and Management Ngaire Kerse, John Scott, Michal Boyd.
ALZHEIMER’S PART 2. AD VIDEO
ALZHEIMER’S DISEASE BY JOSEPH MOLLUSO.
Dementia in Clinical Practice Mary Ann Forciea MD Clinical Prof of Medicine Division of Geriatric Medicine UPHS Photo: Nat Geographic.
Pharmacological Management. Only symptomatic treatment, there is no cure. Acetylcholinesterase inhibitors - Only for mild to moderate dementia –Donepezil.
DEMENTIA AND ALZHEIMER'S DISEASE. IMPAIRMENT OF BRAIN FUNCTION ( DECLINE IN INTELLECTUAL FUNCTIONING) THAT INTERFERES WITH ROUTINE DAILY ACTIVITIES. MENTAL.
By: Tasso Skountzouris David Schiano. General Description  Alzheimer’s is one the most common form of Dementia  Dementia causes a loss of brain function.
Introduction Alzheimer’s is a disease that affects the brain. About 4 million people in the United States have it. It is predicted that 1 in 85 people.
EMS Alzheimer’s Training Alzheimer’s Association of NENY Hollie Gray.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 33 Delirium and Dementia.
NOW WHERE HAVE I PUT MY GLASSES? A DISCUSSION AROUND DEMENTIA Dr Marion Overton U3A SCIENCE 19TH JUNE 2015.
Medical University of Sofia, Faculty of Medicine Department of Pharmacology and Toxicology Alzheimer’s Disease Avi Gandhi (2009)
COLUMBIA PRESBYTARIAN HOSPITAL CENTER
Alzheimer’s Disease  Goals  To understand what dementia is  To explore causes, risk factors, symptoms, and treatments of Alzheimer’s Disease  To better.
ALZHEIMER’S DISEASE Sania Munir Medical Biotechnology (BIOT 412)
Progressive, degenerative disorder Attacks the brain's neurons Results in loss of memory, thinking and language skills, and behavioral changes Confusion.
Dementia. What is Dementia? Dementia is a gradual decline of mental ability that affects your intellectual and social skills to the point where daily.
Do you remember what you ate for dinner two days ago?
ALZHEIMER DISEASE. WHAT IS DEMENTIA? WHAT IS ALZHEIMER?
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
Chapter 16 Development Psychopathology
Alzheimer's: An Investigation into Treatment Options Dana McGuire and Jessica Scharfenberg MPH 543: Leadership and Organizational Management Concordia.
Alzheimer's Disease BIOLOGY 1409 Presentation By XXXXXXXXXX May 3, 2010.
Neurological Disorders
Mosby items and derived items © 2008 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 44 Confusion and Dementia.
Alzheimer's disease M O Jamali, H Saeed & T Mathew.
Alzheimer’s is a type of dementia that causes problems with memory, thinking and behavior. Symptoms usually develop slowly and get worse over time,
Alzheimer’s Disease Today and Tomorrow First case reported in 1906 Reported by Alois Alzheimer Patient Augusta D. first treated at 46 years old Paranoia,
The Facts about Alzheimer’s Disease By: Mr. Frantz.
Regular Exercise  Decrease risk by 50%  Slow further deterioration of the patients mental state  Help the brain by maintaining regular blood flow and.
Alzheimer's disease 蕭尚益 丁唯洋 蔡欣容. Outline introductionDisease mechanismPreventConclusion.
Can we treat Alzheimers 20 years early? 郭丕鈺 王家豪 張琮貿.
We Treat Alzheimers 20 years early? Can. Clinical neurologist-Reisa Sperling 1. Is a clinical neurologist, a neuroimaging researcher. 2.Is a leading force.
The clinical research of early diagnosis and ultimately the treatment of Alzheimer’s disease 許一仁 董冠廷 詹鎮遠 陳柏廷.
Update and Thank you to participants Bradley Hyman MD PhD Director, Mass ADRC ViceChair, Neurology, Massachusetts General Hospital.
DEGENERATIVE DISEASES is a disease in which the function or structure of the affected tissues or organs will progressively deteriorate over time, whether.
Alzheimer Disease: An Overview. What is Dementia? Dementia is a set of symptoms, which includes loss of memory, understanding, and judgment.
Introduction to Dementia
“ I was struggling to keep on top of my diabetes. My Health Advocate nurse made it easy. ” Robert was recently diagnosed with type 2 diabetes and found.
DEMENTIA Shenae Whitfield & Kate Maddock.
Can We Treat Alzheimers 20 years early?
“Community Recreation for Participants with Early Stages of Alzheimer’s Disease: Research and Program Ideas” Tyler Tapps MS.
Vascular Dementia Lewis and Escalin.
Eli Lilly’s Experimental Alzheimer’s Drug Fails in Large Trial
What will it take to develop an effective Alzheimer’s drug?
Five Causes of Decreased Male Organ Sensation and How to Get it Back
Alzheimer’s Disease Medical University of Sofia, Faculty of Medicine
COGNITIVE DECLINE IN THE WORKPLACE
Prostate Cancer Awareness
Modifying Disease Course in Alzheimer's Disease
Figure 19.1 Alzheimer disease and the resulting dementia occur when changes in the brain hamper neurotransmission.
Session Title: Dementia-Breaking The Barriers Speaker Name: Nasseer Masoodi, MD, MBA, FACP Assistant Chair/Senior Consultant; Ambulatory General Internal.
Early Dementia Distinguishing AD From MCI
Chapter 30 Delirium and Dementia
Reisa Sperling, Elizabeth Mormino, Keith Johnson  Neuron 
Chapter 93 Dementias and Related Disorders
INTRODUCING 3 DISEASES THAT AFFECTS THE NERVE SYSTEM
Alzheimer's.
Alzheimer’s Disease and Dementia
I Can’t Find My Keys – Should I Be Worried?
Confusion and Dementia
Introduction Alzheimer’s is a disease that affects the brain. About 4 million people in the United States have it. It is predicted that 1 in 85 people.
Fig. 1. ROC curve for K-IADL to diagnose dementia or MCI
Presentation transcript:

Alzheimer’s Disease Group1 103001021廖元祺 103001023楊熙恆 103001110劉苡萱 102003041陳緯瑾

content Introduction to Alzheimer’s Disease Ted Talk Introduction How to Prevent Alzheimer’s Disease and Retard Deterioration If Our Family Member Has Been Diagnosed With Alzheimer’s Disease

Introduction to Alzheimer’s Disease

Can we treat Alzheimer’s 20 years early? by Reisa Sperling Ted Talk Can we treat Alzheimer’s 20 years early? by Reisa Sperling

Dementia---already been years of irreversible brain demage Mild cognitive impairment---15%(50-70%of some key nerve cells are already lost Preclinical/presymptomatic phase---just look like normal aging

Treatment---antibody to help the brain empty itself the amyloid(in clinical trials---doesn’t show any difference in the Alzheimer’s patients who already lost 70% of their neurons)

Secondary prevention AD trial Prevent or slow the syndrome of patients 2 approaches genetic at risk age at risk Prevent or slow the syndrome of patients who already have Alzheimer’s disease beginning in their brain but don’t yet have any symptoms In order to bend the curve the speaker believes that we should go much earlier to the disease process Secondary prevention AD trial---prevent the emergence of the symptom(2 approaches---genetics,ex. Statin, Age---decreasing amyloid burden will slow downstream neurodegeneration and cognitive decline

How to Prevent Alzheimer’s Disease and Retard Deterioration??

Diet -Vitamin E -Vitamin B Complex -Low cholesterol Exercise Brainstorming

If Our Family Member Has Been Diagnosed With Alzheimer’s Disease

If our family member has been diagnosed with Alzheimer’s disease Encouraging him or her to continue living as independently as possible Helping the person stay organized with shared calendars, notes, medication schedules and other reminder systems Establishing a daily routine and maintaining some regularity will be of benefit

Encouraging the person to share his or her feelings, and asking how you can be supportive Encouraging the person to stay involved in activities he or she enjoys

Q&A

Thank You